Medtronic
-0.02 %
-0.74 %
Yet to be announced
Company Overview
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies. It operates through four segments: Cardiovascular, Neuroscience, Medical Surgical Portfolio, and Diabetes Operating Unit. The Neuroscience Portfolio segment offers products for spinal surgeons, neurosurgeons, neurologists; neurologists, pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists.
Revenue Sources
PassBased on the review of Medtronic's financial statements and business operations, the company's revenue is primarily derived from the development, manufacture, and sale of medical devices and therapies. These activities are halal as they provide essential healthcare solutions that help save and improve lives.
The company does not generate revenue from prohibited sources such as alcohol, gambling, pork products, or other haram activities.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Jan. 24, 2025 | $8.29b | $6.83b | - | $179.0m | 0.00% | 2.62% |
| Oct. 25, 2024 | $8.4b | $7.02b | - | $209.0m | 0.00% | 2.98% |
| July 26, 2024 | $7.92b | $6.8b | - | $167.0m | 0.00% | 2.46% |
| April 26, 2024 | $8.59b | $7.74b | - | $203.0m | 0.00% | 2.62% |
Looking at the last four quarters' financial data, interest expense ranged from $167M to $209M per quarter, while total expenses ranged from $6.8B to $7.7B. The interest expense to total expense ratio has consistently remained below 5% across all quarters analyzed.
The company's interest income is negligible, and its core business model does not rely on interest-based income.
Operational Ethics
PassBased on review of public documents and company disclosures, Medtronic maintains standard business operations in various countries but does not have significant direct partnerships or material ongoing projects with entities involved in human rights violations.
Comments